BVS logo

BVS

Bioventus Inc.

$6.94
+$0.01(+0.14%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$463.56M
Volume
199.48K
52W Range
$5.81 - $14.38
Target Price
$12.75
Order:

Income Statement

MetricTrendChart
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$430.9M$512.1M$512.3M$573.3M
Total Revenue
$430.9M$512.1M$512.3M$573.3M
COST OF GOODS SOLD
Cost of Revenue
$128.2M$181.0M$184.2M$185.1M
GROSS PROFIT
Gross Profit
$302.7M$331.1M$328.2M$388.2M
OPERATING EXPENSES
Operating Expenses
$276.0M$365.7M$326.2M$362.2M
Research & Development
$19.0M$23.9M$13.4M$13.6M
Research Expense
$19.0M$23.9M$13.4M$13.6M
Selling, General & Administrative
$254.3M$332.1M$303.9M$340.9M
Selling & Marketing Expenses
$3.9M$5.2M$3.9M$4.4M
General & Administrative Expenses
$254.3M$332.1M$303.9M$340.9M
Promotion & Advertising
$3.9M$5.2M$3.9M$4.4M
Salaries & Wages
$-5.7M$17.1M$2.4M$9.6M
Depreciation & Amortization
$8.4M$9.7M$8.8M$7.7M
Depreciation & Amortization
$8.4M$9.7M$8.8M$7.7M
Amortization
$707.4M$76.7M$69.1M$63.9M
Other Operating Expenses
$4.1M$5.3M$-142.0K$-456.0K
OPERATING INCOME
Operating income
$12.1M$-167.2M$-81.7M$-12.0M
EBITDA
$42.5M$-121.6M$-62.9M$-48.3M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$12.0M$823.0K$866.0K
Intinc
$-1.1M$-12.0M$-40.7M$-38.8M
Net Non-Operating Interest Income/Expense
$-1.1M$12.0M$-40.7M$-38.8M
Other Income/Expense
$4.2M$-142.3M$81.6M$36.4M
Other Special Charges
$-3.3M$-9.8M$1.3M$1.6M
SPECIAL ITEMS
Restructring And Mn A Income
$2.5M$6.8M$840.0K$-52.0K
Special Income Charges
$-2.5M$-6.8M$-840.0K$52.0K
Impairment of Capital Assets
$5.7M$189.2M$78.6M--
PRE-TAX INCOME
EBIT
$7.6M$-177.0M$-120.3M$-48.3M
Pre-Tax Income
$7.6M$-189.0M$-121.1M$-49.1M
INCOME TAX
Tax Provision
$-2.0M$-44.4M$85.0K$-5.3M
NET INCOME
Net Income
$19.4M$-158.7M$-156.2M$-33.5M
Net Income (Continuing Operations)
$19.4M$-144.7M$-121.2M$-43.8M
Net Income (Discontinued Operations)
$19.4M$-158.7M$-156.2M$-33.5M
Net Income (Common Stockholders)
$19.4M$-158.7M$-156.2M$-33.5M
Normalized Income
------$-20.0M
TOTALS
Total Expenses
$404.2M$546.8M$510.3M$547.2M
SHARE & EPS DATA
Average Shares Outstanding
$45.5M$61.4M$62.6M$64.5M
Average Shares Outstanding (Diluted)
$45.5M$61.4M$62.6M$64.5M
Shares Outstanding
$76.4M$78.1M$79.2M$81.9M
Basic EPS
$-0.15$-2.59$-2.49$-1.04
Basic EPS (Continuing Operations)
$-0.15$-2.59$-4.03$-1.04
Diluted EPS
$-0.15$-2.59$-2.49$-1.04
Diluted EPS (Continuing Operations)
$-0.15$-2.59$-4.03$-1.04
OTHER METRICS
Basic Discontinuous Operations
----$-0.95--
Diluted Discontinuous Operations
----$-0.95--
Gain On Sale Of Business
----$-3.6M$-292.0K
Gain On Sale Of P P E
----$-2.0M--
Minority Interests
$9.8M$54.7M$39.4M$10.3M
Net Income Discontinuous Operations
--$-68.7M$-74.4M--
Other Gain Loss From Disposition Of Discontinued Operations
--$-68.7M$-74.4M--
Other Gand A
$254.3M$332.1M$303.9M$340.9M
Other Impairment Of Capital Assets
----$78.6M$36.4M
Other Write Off
$-173.0K$-535.0K$-1.6M$-3.6M
Restruct
$2.5M$6.8M$840.0K$-52.0K

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BVS$6.94+0.1%199.48K
3
4
5
6

Get Bioventus Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.